The authors would like to state a misinterpretation of the findings of Professor Timmons and his coworkers in Reference 61 [Gallagher et al 2010. Genome Med. 2(2):9]. The authors wish to add: "A separate miRNA profiling study by Gallagher et al  using muscle tissue biopsies of impaired glucose tolerance (IGT) and T2D individuals showed 62 dysregulated miRNAs of which miR-144, miR-106b, miR-142-3p, miR-185, miR-451, miR-589, miR-665, miR-668, miR-126*, miR-199a-3p, miR-208a, miR-30e, miR-331-3p, miR-342-3p, miR-374a and miR-374b showed similar expression pattern as observed in our human/animal model studies. Moreover, miR-144 was also found to be highly up-regulated (with a fold change of 2.6) in their T2D samples."
Citation: Karolina DS, Armugam A, Tavintharan S, Wong MTK, Lim SC, Sum CF, et al. (2011) Correction: MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus. PLoS ONE 6(9): 10.1371/annotation/698b7123-174f-4a09-95c9-fd6f5017d622. https://doi.org/10.1371/annotation/698b7123-174f-4a09-95c9-fd6f5017d622
Published: September 02, 2011
Copyright: © 2011 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests: No competing interests declared.